NO975692D0 - Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi - Google Patents

Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi

Info

Publication number
NO975692D0
NO975692D0 NO975692A NO975692A NO975692D0 NO 975692 D0 NO975692 D0 NO 975692D0 NO 975692 A NO975692 A NO 975692A NO 975692 A NO975692 A NO 975692A NO 975692 D0 NO975692 D0 NO 975692D0
Authority
NO
Norway
Prior art keywords
biphosphonates
connection
bone loss
immunosuppressive therapy
prevent bone
Prior art date
Application number
NO975692A
Other languages
English (en)
Other versions
NO975692L (no
Inventor
Anastasia G Daifotis
Ashley J Yates
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO975692D0 publication Critical patent/NO975692D0/no
Publication of NO975692L publication Critical patent/NO975692L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO975692A 1995-06-06 1997-12-05 Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi NO975692L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/471,466 US5616571A (en) 1995-06-06 1995-06-06 Bisphosphonates prevent bone loss associated with immunosuppressive therapy
PCT/US1996/008398 WO1996039151A1 (en) 1995-06-06 1996-06-03 Bisphosphonates prevent bone loss associated with immunosuppressive therapy

Publications (2)

Publication Number Publication Date
NO975692D0 true NO975692D0 (no) 1997-12-05
NO975692L NO975692L (no) 1997-12-05

Family

ID=23871741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975692A NO975692L (no) 1995-06-06 1997-12-05 Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi

Country Status (14)

Country Link
US (1) US5616571A (no)
EP (1) EP0831844A4 (no)
JP (1) JPH11507044A (no)
KR (1) KR19990022380A (no)
CA (1) CA2223400A1 (no)
CZ (1) CZ288906B6 (no)
EA (1) EA000964B1 (no)
HU (1) HUP9900886A3 (no)
IL (1) IL122149A (no)
NO (1) NO975692L (no)
NZ (1) NZ310000A (no)
PL (1) PL323797A1 (no)
SK (1) SK163797A3 (no)
WO (1) WO1996039151A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195075T1 (de) * 1991-11-22 2000-08-15 Procter & Gamble Pharma Risedronat enthaltende arzneimittel mit verzögerter wirkstoffabgabe
EA000347B1 (ru) * 1995-02-17 1999-04-29 Мерк Энд Ко., Инк. Способ уменьшения риска невертебральных переломов костей
EP1007054A4 (en) * 1996-10-04 2000-07-19 Merck & Co Inc LIQUID ALENDRONATE FORMULATIONS
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
AU741818C (en) * 1997-07-22 2003-01-09 Merck Sharp & Dohme Corp. Method for inhibiting bone resorption
US6087350A (en) 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
US6414006B1 (en) 1998-10-15 2002-07-02 Merck Frosst Canada & Co. Methods for inhibiting bone resorption
CA2346031A1 (en) * 1998-10-15 2000-04-20 Merck & Co., Inc. Methods for stimulating bone formation
US6331533B1 (en) 1998-11-16 2001-12-18 Merck & Co., Inc. Method for inhibiting dental resorptive lesions
HUP0200871A3 (en) 1999-05-04 2004-04-28 Strakan Int Ltd Androgen glycosides and androgenic activity thereof
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
US6677320B2 (en) * 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
AU2001243385B2 (en) * 2000-03-02 2006-11-02 University Of Pittsburgh Of The Commonwealth System Of Higher Education Combination chemotherapy
JP4354698B2 (ja) * 2001-03-01 2009-10-28 エミスフェアー・テクノロジーズ・インク ビスホスホネートデリバリー用組成物
EP1494683A1 (en) * 2002-04-05 2005-01-12 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
US20040097468A1 (en) * 2002-11-20 2004-05-20 Wimalawansa Sunil J. Method of treating osteoporosis and other bone disorders with upfront loading of bisphosphonates, and kits for such treatment
US20050181043A1 (en) * 2004-02-12 2005-08-18 Indranil Nandi Alendronate salt tablet compositions
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
US20060134190A1 (en) * 2004-12-16 2006-06-22 Banner Pharmacaps Inc. Formulations of bisphosphonate drugs with improved bioavailability
JP2008533173A (ja) * 2005-03-17 2008-08-21 エラン ファーマ インターナショナル リミテッド ナノ粒子ビスホスホネート組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530603D0 (en) * 1985-12-12 1986-01-22 Leo Pharm Prod Ltd Chemical compounds
SK74594A3 (en) * 1991-12-17 1995-01-12 Procter & Gamble Pharma Treatment for treating of osteoporosis
AU659329B2 (en) * 1992-06-30 1995-05-11 Procter & Gamble Pharmaceuticals, Inc. Use of phosphonates for the treatment of osteoporosis
US5578593A (en) * 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
CA2151240A1 (en) * 1992-12-23 1994-07-07 Donna T. Whiteford Biophosphonate/estrogen therapy for treating and preventing bone loss
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
TW398975B (en) * 1994-07-22 2000-07-21 Lilly Co Eli Pharmaceutical composition for inhibiting bone loss
US5780455A (en) * 1994-08-24 1998-07-14 Merck & Co., Inc. Intravenous alendronate formulations
CN1157566A (zh) * 1994-09-09 1997-08-20 普罗克特和甘保尔公司 用于骨质疏松症的膦酸盐类和甲状旁腺激素

Also Published As

Publication number Publication date
HUP9900886A3 (en) 2002-04-29
CA2223400A1 (en) 1996-12-12
SK163797A3 (en) 1998-07-08
CZ288906B6 (cs) 2001-09-12
EP0831844A1 (en) 1998-04-01
EA000964B1 (ru) 2000-08-28
IL122149A (en) 2001-03-19
PL323797A1 (en) 1998-04-27
JPH11507044A (ja) 1999-06-22
KR19990022380A (ko) 1999-03-25
EP0831844A4 (en) 1998-12-30
HUP9900886A2 (hu) 2001-04-28
AU696097B2 (en) 1998-09-03
US5616571A (en) 1997-04-01
NO975692L (no) 1997-12-05
WO1996039151A1 (en) 1996-12-12
NZ310000A (en) 2000-07-28
AU6030996A (en) 1996-12-24
CZ389897A3 (cs) 1998-07-15
EA199800011A1 (ru) 1998-06-25
IL122149A0 (en) 1998-04-05

Similar Documents

Publication Publication Date Title
NO975692D0 (no) Bifosfonater som forhindrer tap av benmasse i forbindelse med immunsuppressiv terapi
FR2739911B3 (fr) Robinet tournant perfectionne
NO983692D0 (no) Skruegjengeimplantat
HK1001778A1 (en) Multi-way valve and water purifier using the same
EP0677619A3 (en) Flow deflector and purifier provided with such a deflector.
AU3745895A (en) Use of gaba antagonists in the treatment of emesis
FR2737847B1 (fr) Implant-taraud comprimant
GB2309731B (en) Tap
AU2160697A (en) Nsaids in the treatment of pruritus
GB9500595D0 (en) Tap
GB9617124D0 (en) Improvement in the lavatory
GB9613745D0 (en) Optical connection in HV line
GB9417854D0 (en) Tap spanner
KR960010195U (ko) 다단계 스패너
FR2714142B1 (fr) Raccord, notamment pour la liaison de deux éléments de tuyauterie.
BR7402441U (pt) Disposiçao construtiva em adaptador par torneira
GB9609635D0 (en) Stop tap
KR970006481A (ko) 장에서 집락화하는 유산간균
BR7301499U (pt) Disposição construtiva em encaixe odontológico
ITRM960826A0 (it) Sicur tap
AUPN867296A0 (en) The designer tap
KR970004549U (ko) 탭렌치
PL102040U1 (en) Three-way ball cock
NO944262D0 (no) Svingjern
IT235698Y1 (it) Rubinetto perfezionato

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application